Portal hypertension is a major complication of cirrhosis, and its consequences, including
ascites, esophageal varices, hepatic encephalopathy, and hepatorenal syndrome, lead to …

Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in
the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in …

This guidance provides a data-supported approach to risk stratification, diagnosis, and
management of patients with cirrhosis and portal hypertension (PH). A guidance document …

These recommendations provide a data-supported approach to the management of patients
with varices and variceal hemorrhage. They are based on the following:(1) formal review …

Portal hypertension is a severe, almost unavoidable complication of chronic liver diseases
and is responsible for the main clinical consequences of cirrhosis. Measurement of the …

Background & Aims: Our aim was to identify predictors of clinical decompensation (defined
as the development of ascites, variceal hemorrhage [VH], or hepatic encephalopathy [HE]) in …

Among the common complication of cirrhosis portal hypertension witnessed a major
improvement of prognosis during the past decades. Principally due to the introduction of …

The clinical course of alcoholic cirrhosis, a condition with a high mortality, has not been well
described. We examined prevalence, risk, chronology, and mortality associated with three …

BACKGROUND & AIMS: We evaluated the gastrointestinal permeability and bacterial
translocation in cirrhotic patients with portal hypertension (PHT) prior to and after non …

Bacterial infections are an important complication of cirrhosis, particularly in hospitalized
patients. In this article we review the prevalence, risk factors, and pathogenesis of bacterial …